James Investment Research’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.44M | Buy |
3,724
+972
| +35% | +$360K | 0.15% | 140 |
|
|
2026
Q1 | $806K | Buy |
2,752
+1,264
| +85% | +$415K | 0.09% | 194 |
|
|
2025
Q4 | $522K | Sell |
1,488
-273
| -16% | -$92.3K | 0.06% | 239 |
|
|
2025
Q3 | $569K | Sell |
1,761
-119
| -6% | -$37K | 0.06% | 223 |
|
|
2025
Q2 | $731K | Sell |
1,880
-162
| -8% | -$65.2K | 0.09% | 178 |
|
|
2025
Q1 | $888K | Sell |
2,042
-82
| -4% | -$32.9K | 0.11% | 158 |
|
|
2024
Q4 | $784K | Sell |
2,124
-4,479
| -68% | -$1.87M | 0.09% | 174 |
|
|
2024
Q3 | $3.43M | Sell |
6,603
-9
| -0.1% | -$4.81K | 0.4% | 73 |
|
|
2024
Q2 | $3.58M | Sell |
6,612
-6
| -0.1% | -$3.17K | 0.43% | 68 |
|
|
2024
Q1 | $3.43M | Buy |
6,618
+840
| +15% | +$418K | 0.41% | 75 |
|
|
2023
Q4 | $2.72M | Sell |
5,778
-561
| -9% | -$259K | 0.34% | 85 |
|
|
2023
Q3 | $2.76M | Sell |
6,339
-46
| -0.7% | -$20.9K | 0.36% | 81 |
|
|
2023
Q2 | $2.84M | Sell |
6,385
-245
| -4% | -$113K | 0.36% | 81 |
|
|
2023
Q1 | $3.05M | Sell |
6,630
-339
| -5% | -$161K | 0.4% | 80 |
|
|
2022
Q4 | $3.58M | Sell |
6,969
-8
| -0.1% | -$4.06K | 0.5% | 67 |
|
|
2022
Q3 | $3.17M | Sell |
6,977
-149
| -2% | -$71.3K | 0.45% | 72 |
|
|
2022
Q2 | $3.44M | Buy |
7,126
+1,252
| +21% | +$619K | 0.46% | 69 |
|
|
2022
Q1 | $2.88M | Buy |
5,874
+1,877
| +47% | +$858K | 0.3% | 87 |
|
|
2021
Q4 | $1.85M | Sell |
3,997
-92
| -2% | -$38.7K | 0.17% | 126 |
|
|
2021
Q3 | $1.52M | Sell |
4,089
-7,375
| -64% | -$2.8M | 0.14% | 125 |
|
|
2021
Q2 | $4.38M | Sell |
11,464
-548
| -5% | -$209K | 0.37% | 79 |
|
|
2021
Q1 | $4.31M | Sell |
12,012
-10,280
| -46% | -$3.31M | 0.39% | 80 |
|
|
2020
Q4 | $7.16M | Sell |
22,292
-2,626
| -11% | -$806K | 0.64% | 54 |
|
|
2020
Q3 | $6.69M | Sell |
24,918
-13,991
| -36% | -$3.76M | 0.62% | 49 |
|
|
2020
Q2 | $10.2M | Sell |
38,909
-1,131
| -3% | -$302K | 0.96% | 28 |
|
|
2020
Q1 | $9.09M | Sell |
40,040
-19,012
| -32% | -$5.18M | 0.94% | 28 |
|
|
2019
Q4 | $17.8M | Sell |
59,052
-667
| -1% | -$184K | 1.24% | 16 |
|
|
2019
Q3 | $14.3M | Sell |
59,719
-13,402
| -18% | -$3.67M | 1.04% | 23 |
|
|
2019
Q2 | $20.6M | Buy |
73,121
+8,422
| +13% | +$2.3M | 1.5% | 13 |
|
|
2019
Q1 | $18.6M | Sell |
64,699
-35,825
| -36% | -$10.4M | 1.21% | 14 |
|
|
2018
Q4 | $26.4M | Buy |
100,524
+15,599
| +18% | +$4.29M | 1.64% | 7 |
|
|
2018
Q3 | $23.3M | Sell |
84,925
-655
| -0.8% | -$170K | 0.96% | 17 |
|
|
2018
Q2 | $20.4M | Sell |
85,580
-8,180
| -9% | -$1.89M | 0.78% | 25 |
|
|
2018
Q1 | $20.6M | Sell |
93,760
-2,756
| -3% | -$647K | 0.77% | 26 |
|
|
2017
Q4 | $21.7M | Sell |
96,516
-2,885
| -3% | -$614K | 0.74% | 33 |
|
|
2017
Q3 | $18.9M | Sell |
99,401
-40,052
| -29% | -$7.62M | 0.63% | 44 |
|
|
2017
Q2 | $26.2M | Buy |
139,453
+48,892
| +54% | +$8.78M | 0.81% | 35 |
|
|
2017
Q1 | $15M | Sell |
90,561
-1,095
| -1% | -$174K | 0.42% | 78 |
|
|
2016
Q4 | $13.2M | Sell |
91,656
-3,685
| -4% | -$493K | 0.34% | 104 |
|
|
2016
Q3 | $11.9M | Sell |
95,341
-255,957
| -73% | -$33M | 0.32% | 102 |
|
|
2016
Q2 | $46.1M | Sell |
351,298
-232,947
| -40% | -$31.9M | 1.17% | 23 |
|
|
2016
Q1 | $81.2M | Buy |
584,245
+73,581
| +14% | +$9.83M | 1.98% | 5 |
|
|
2015
Q4 | $71.2M | Buy |
510,664
+14,878
| +3% | +$2.05M | 1.76% | 9 |
|
|
2015
Q3 | $69.4M | Buy |
495,786
+55,555
| +13% | +$8.35M | 1.85% | 7 |
|
|
2015
Q2 | $72.3M | Buy |
440,231
+71,982
| +20% | +$11.5M | 1.69% | 9 |
|
|
2015
Q1 | $56.9M | Buy |
368,249
+87,268
| +31% | +$12.4M | 1.34% | 17 |
|
|
2014
Q4 | $35.3M | Buy |
280,981
+64,205
| +30% | +$7.93M | 0.96% | 29 |
|
|
2014
Q3 | $25.9M | Buy |
216,776
+15,064
| +7% | +$1.73M | 0.81% | 36 |
|
|
2014
Q2 | $21.7M | Buy |
201,712
+56,382
| +39% | +$5.81M | 0.69% | 47 |
|
|
2014
Q1 | $14.5M | Buy |
145,330
+239
| +0.2% | +$21.6K | 0.46% | 74 |
|
|
2013
Q4 | $13.4M | Buy |
145,091
+24,577
| +20% | +$2.18M | 0.42% | 79 |
|
|
2013
Q3 | $10.1M | Buy |
120,514
+68,376
| +131% | +$5.86M | 0.38% | 86 |
|
|
2013
Q2 | $4.27M | Buy |
+52,138
| New | +$3.9M | 0.18% | 113 |
|
Other funds holding ELV
James Investment Research's ELV Position: Q2 2026 in Review
James Investment Research increased its Elevance Health (ELV) stake by 35% in Q2 2026, buying an estimated $360K and bringing the position to 3,724 shares worth $1.44M. The position accounts for 0.15% of the portfolio, ranked #140.
James Investment Research first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.2M in Q1 2016. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- James Investment Research held 3,724 shares of Elevance Health worth $1.44M as of Q2 2026.
- James Investment Research bought 972 Elevance Health shares in Q2 2026, an estimated $360K.
- Elevance Health made up 0.15% of James Investment Research's portfolio in Q2 2026, its #140 holding.
- James Investment Research first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- James Investment Research's Elevance Health position peaked at $81.2M in Q1 2016.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.